Clinical Efficacy and Safety Evaluation of HCP1202 in COPD Patients

Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers

NCT04714294 ·Status: UNKNOWN ·Phase: PHASE1

A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® (Kronos)

NCT02497001 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Pharmacokinetic Characteristics, Safety, Tolerability, and Preliminary Efficacy of 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD).

NCT06175351 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of CHF6297 in Healthy Subjects and Patients With COPD

NCT02815488 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Clinical Study Evaluating the Pharmacokinetics and Pharmacodynamics of HSK39004 Inhalation Suspension in COPD Patients

NCT07331402 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Multi-center Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of R7103 Following Repeated Inhalation in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease

NCT01009424 ·Status: WITHDRAWN ·Phase: PHASE1

Effect on Structural Changes in Airways, Measured by MSCT, of Twice Daily 60mg AZD9668 for 12 Weeks in Chronic Obstructive Pulmonary Disease (COPD) Patients

NCT01054170 ·Status: COMPLETED ·Phase: PHASE2

Pharmacodynamics, Pharmacokinetics and Safety of Two Doses of CHF6001 DPI in Subjects With Moderate, Severe COPD

NCT03004417 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety and Efficacy of Inhaled PT001 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00871182 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

To Assess the Efficacy and Safety of PT010 Compared to PT009 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

NCT03081247 ·Status: WITHDRAWN ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients With COPD

NCT06643078 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease

NCT07147946 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease

NCT06154837 ·Status: RECRUITING ·Phase: PHASE1

A Study To Assess Single Dosage Strength Of GW685698/GW642444 Chronic Obstructive Pulmonary Disease (COPD)

NCT00731822 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of PT009, PT008, and PT005 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT02196077 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD

NCT07116889 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Effect of Symbicort on HAT and HDAC in Sputum Macrophages of COPD

NCT00291408 ·Status: WITHDRAWN ·Phase: PHASE4

Evaluate the Efficacy and Safety of GSK573719 Delivered Via a Novel Dry Powder Inhaler in Subjects With COPD

NCT01387230 ·Status: COMPLETED ·Phase: PHASE3

A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder

NCT07252908 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Study in Patients With COPD

NCT00215449 ·Status: COMPLETED ·Phase: PHASE3

A Trial to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients with COPD

NCT06619210 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of Symbicort Turbuhaler in Chinese Patients With COPD

NCT00421122 ·Status: COMPLETED ·Phase: PHASE3

Phase II Study to Evaluate the Cardiac Safety of 2 Doses of CHF5993 Both Combined With CHF1535 BID Versus CHF1535 BID in Patients With Moderate to Severe COPD

NCT01584505 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety and Tolerability of NVA237 in Patients With Chronic Obstructive Pulmonary Disease

NCT01566604 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Safety and Efficacy of PT010, PT003, and PT009 in Japanese Subjects With COPD Compared With Symbicort® Turbohaler®

NCT03262012 ·Status: COMPLETED ·Phase: PHASE3